The Cancer Immunology and Immunotherapy Center (CIIC) was founded in 1996 to investigate the field of cancer immunology, which is based on the premise that the body's immune system can be mobilized against cancer. This field, which CIIC helped progress, has provided the basis for the development of cancer immunotherapy. Research at the Cancer Immunology and Immunotherapy Center (CIIC) is dedicated to experimental cancer research, in close collaboration with the adjacent "Saint Savas" Cancer Hospital.

Drawing upon the expertise of internationally renowned researchers and clinicians from the Schools of Biology and Medicine, the Cancer Immunology and Immunotherapy Center is at the forefront of today's advances in cancer research and cancer immunotherapy.

Interdisciplinary research by CIIC experts in cancer biology, cancer immunology and immunotherapy and other fields is yielding critical insights into the origins of cancer, while collaborations between the lab and clinic are working to move the most promising discoveries into improved diagnostic, treatment and prevention strategies.

Patients seeking care at St Savas Cancer Hospital may gain early access to these emerging therapies—and the benefits that they may offer—through the center’s clinical trials program.